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SUMMARY
LYMFASIM is a simulation model for lymphatic filariasis transmission and control. We quantified its parameters to
simulate Wuchereria bancrofti transmission by Anopheles mosquitoes in African villages, using a wide variety of reported
data. The developedmodel captures the general epidemiological patterns, but also the differences between communities. It
was calibrated to represent the relationship between mosquito biting rate and the prevalence of microfilariae (mf) in the
human population, the age-pattern in mf prevalence, and the relation between mf prevalence and geometric mean mf
intensity. Explorative simulations suggest that the impact of mass treatment depends strongly on the mosquito biting rate
and on the assumed coverage, compliance and efficacy. Our sensitivity analysis showed that some biological parameters
strongly influence the predicted equilibrium pre-treatment mf prevalence (e.g. the lifespan of adult worms and mf). Other
parameters primarily affect the post-treatment trends (e.g. severity of density dependence in the mosquito uptake of
infection from the human blood, between-person variability in exposure to mosquito bites). The longitudinal data, which
are being collected for evaluation of ongoing elimination programmes, can help to further validate the model. The model
can help to assess when ongoing elimination activities in African populations can be stopped and to design surveillance
schemes. It can be a valuable tool for decision making in the Global Programme to Eliminate Lymphatic Filariasis.
Key words: lymphatic filariasis,Wuchereria bancrofti, Anopheles, transmission dynamics, simulation model, Africa, mass
treatment, elimination.
INTRODUCTION
Lymphatic filariasis (LF) is a tropical disease, which
is caused by lymphatic-dwelling filarial parasites and
is transmitted by mosquitoes that engorge the im-
mature larval forms (microfilariae, mf) with a blood
meal. Wuchereria bancrofti is responsible for >90%
of all infections worldwide, while Brugia malayi
and Brugia timori account for the remaining infec-
tions. Chronic infection with LF can cause gross
swelling of extremities or the scrotum (lymphoedema,
hydrocoele). The Global Programme to Eliminate
Lymphatic Filariasis aims to eliminate this debili-
tating disease as a public health problem (World
HealthOrganization, 2006). Yearlymass treatment is
provided to reduce themf reservoir to such low levels
that transmission becomes insignificant and is even-
tually interrupted. However, questions are being
raised about the feasibility of elimination (Gyapong
and Twum-Danso, 2006). In fact, we do not know
how long mass drug administration should be con-
tinued, how that depends on local conditions, or how
we can establish that transmission interruption is
achieved. Models can help to answer these questions
and further development ofmathematical models has
been identified as a priority in LF research (Dadzie,
Basa´n˜ez and Richards, 2004).
Several models have been developed for the
simulation of LF transmission and control (Chan
et al. 1998; Plaisier et al. 1998; Rochet, 1990). All
three models were quantified for W. bancrofti infec-
tion and validated using the detailed longitudinal
epidemiological and entomological data that were
available from urban Pondicherry in India (Chan
et al. 1998; Subramanian et al. 2004). Thus far, the
role of these models in decision support in control
programmes is still modest. The main reason is that
model predictions made for Pondicherry are not
necessarily generalisable to other areas. If adjust-
ments are made for differences in exposure to
mosquito bites, then the model should be valid
for other Indian areas, assuming that the basic bio-
logical assumptions are correct. However, the model
cannot be used in regions with other vector or
parasite species, because of known differences in the
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transmission dynamics (Southgate, 1992; Snow and
Michael, 2002; Snow et al. 2006). To support deci-
sion making in the elimination programmes world-
wide, we need vector-parasite specific, validated
model variants (Dadzie et al. 2004; Stolk, de Vlas and
Habbema, 2006).
The LYMFASIM program provides a flexible
framework for simulating LF transmission and con-
trol (Plaisier et al. 1998). It can easily be adjusted to
reflect the transmission dynamics in specific areas or
to test models with alternative assumptions about the
mechanisms involved in transmission. In this paper,
we show how the parameters of LYMFASIM can
be quantified to simulate W. bancrofti transmission
by Anopheles mosquitoes in African communities.
Emphasis is on capturing the general epidemiological
patterns, but also the differences between com-
munities. Therefore, the model is tested against
cross-sectional data from many different locations,
including data on the relationship between mosquito
biting rates and local endemicity levels. A detailed
sensitivity analysis is performed to explore how
changes in parameter values influence the predicted
long-term impact of mass treatment. For another
example of the applicability of such an approach to
modelling the transmission and control of another
vector-borne infection, we refer to Smith et al. (2008,
in this special issue).
MATERIALS AND METHODS
The LYMFASIM simulation model
LYMFASIM simulates the spread ofW. bancrofti in
a human community and the impact of control
measures. A formal mathematical description of the
model is provided elsewhere (Plaisier et al. 1998).
Appendix 1 summarizes itsmain features andTable 1
explains the symbols that are used in the following
section. A schematic representation of the variables
and processes involved in transmission is provided in
Fig. 1.
Quantification of the model for Africa
In a previous study, all parameters of LYMFASIM
were quantified for simulating the transmission of
Wuchereria bancrofti by Culex quinquefasciatus mos-
quitoes in Pondicherry, India (Subramanian et al.
2004). We now set out to quantify the parameters for
Africa. However, we changed the assumptions about
immunity. The Pondicherry model included strong
acquired immunity to explain that infection levels
declined in elderly individuals (Subramanian et al.
2004). Epidemiological data from Africa provide no
indication of patterns consistent with such acquired
immunity (Stolk et al. 2004), and we discard it in the
current model.
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Fig. 1. Schematic representation of LYMFASIM, showing the processes that determine parasite transmission and
the worm load in humans. The diagram shows the time-dependent model variables (boxes) and their interrelation
(arrows). The associated model parameters are given along the arrows. Subscript ‘ i ’ indicates variables and parameters
that vary between individuals. Processes related to optional immune responses are not included in the figure. See
Appendix 1 for further explanation.
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Some model parameters can take the same value in
the models for Pondicherry and Africa because their
value is independent of the area under study and
vector species. This presumably applies to para-
meters that relate to infection in the human host,
including several parameters of the parasite life cycle
(Tl, Ti, Tmf, r0, aTl) and the aggregation parameter
(k) of the negative binomial distribution that quan-
tifies the stochastic variability in mf counts in human
blood samples. For the age-pattern in human ex-
posure to mosquitoes, we assume that the exposure
is zero in newborns (E0) and that the maximum ex-
posure is achieved in adults at age 20.
The uptake curve, which describes the relation
between the mf density in human blood and the
number of L3 developing inmosquitoes after a blood
meal, depends on the vector species involved in
transmission. The uptake curve was quantified for
Anopheles by analyzing published data from feeding
experiments (see Appendix 2). The estimated curve
shows ‘facilitation’, which means that the number of
L3 developing in mosquitoes from a blood meal
increases initially at a rate higher than that expected
from a linearly proportional relationship with the
mf density in the human blood. Only at higher mf
densities, limiting mechanisms seem to operate so
that saturation occurs (‘ limitation’).
The demographic parameters vary considerably
between India and Africa, but within Africa they also
vary between locations. For the current study, we
take the overall population in Sub Saharan Africa
as reference. We used the Revised Global Burden
of Disease 2002 estimates of numbers of deaths by
age and sex in the WHO ‘AFRO Region’ as a whole
to calculate average age-specific death rates. (Data
can be downloaded in spreadsheet format from the
World Health Organization website, www.who.int.)
These death rates were then used to construct a life
table for the African region. Age-specific fertility
rates for Sub-Sahara Africa were available from
the US Census Bureau (2004). Exact quantification
of fertility and mortality rates does not necessarily
result in realistic age-structure of the simulated
population, if historic trends in the rates over time
and migration effects are ignored. To verify whether
the age-structure of the simulate population is suffi-
ciently adequate, we compared it with published
population pyramids for sub Saharan Africa (US
Census Bureau, 2004).
The average monthly biting rate (mbr) was the
only parameter which we assumed to be varying
between communities.We adjusted this parameter to
simulate different endemicity levels. From published
entomological studies, which measured the annual
biting rate based on repeated all-night human land-
ing catches, we estimated the range of possible values
for the average mbr.
Two parameters were unknown and were esti-
mated by fitting the model to data : (1) the success
ratio sr, i.e. the probability that an infectious L3
larva, which is released during a mosquito blood
meal, survives to develop into a mature adult worm;
and (2) the variability in exposure to mosquito bites
(defined by shape parameter aE of the gamma dis-
tribution). The Pondicherry-derived estimates for
these parameters cannot be used because they were
conditional on the inclusion of acquired immunity.
In fact, a third parameter is also unknown, namely
the fraction of the L3 larvae resulting from a single
blood meal that is eventually released by a mosquito
(v). However, v and sr are linear multiplication
factors in the same sequence of calculations and
cannot be estimated independently ; therefore, we
fixed v at a biologically plausible value of 0.1 and only
estimated the success ratio sr.
Fitting procedure
We did a grid search to determine the values for the
two unknown parameters that resulted in the best fit
of model outcomes to data, based on visual assess-
ment. For each pair of values for the success ratio (sr)
and variability in exposure (aE), we performed a
series of 3100 simulation runs. Each series consisted
of 100 repeated runs for 31 different mbr values,
ranging from 100 to 4000 bites per person per month
(mbr 100, 150, …, 1000; larger increments there-
after). All runs started with a 125-year ‘burn-in’
period to achieve a dynamic equilibrium endemicity
level and a population with stable age-sex compo-
sition and an average size of about 6000 individuals.
The results of each series of runs were summarized,
to allow comparison with field data.
A well-fitting model had to satisfy the following
three criteria. Firstly, the simulated relationship
betweenmbr and overall mf prevalence should match
that observed in various localities of the African re-
gion. Observed data about the relationship between
overall mf prevalence and average monthly biting
rate were obtained from a PubMed literature search.
We only included studies from locations in Sub-
Saharan Africa where Anopheles mosquitoes act as
the main vectors. Studies were excluded if the largest
part of sampled mosquitoes were C. quinquefasciatus
and notAnopheles. Selected studies used repeated all-
night human landing catches to measure the biting
rate. Because only few studies were available, we did
not impose selection criteria on the type of test used
for diagnosing microfilaraemia in this part of the
fitting procedure.
The simulation results are represented by a single
curve, which provides the expected average mf
prevalence by mbr. We anticipated that deviations
of observations from the theoretical curve would
be large, because the field data are subject to
many sources of variation that are not considered in
the model. To assess whether these deviations are
still acceptable (i.e. whether they represent natural
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variationor indicatedeviations thatwould cast doubts
on the model), we calculated the range of possible
model outcomes that would be obtained if model re-
sultswere subjected to the same sources of variation as
those in the field data. Unpublished field data from
Ghana suggest that the annual biting rate (or simi-
larly, the annual mean mbr) can vary over time by a
factor of approximately 3 around its average value (Dr
D. Boakye, personal communication). This reflects
measurement error and sampling variation, but also
true fluctuations in the vector density and biting rate
over time. We assumed that the variation around
the log (mbr) is described by a uniform distribution,
which ranges from log (mbr/3) to log (3 mbr). We also
considered sampling variation in measuring human
mf prevalence levels, assuming that the variability is
described by a normal distribution, with the average
simulated mf prevalence as expected value p and
standard deviation
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
p(1xp)=N
p
, i.e. using the nor-
mal approximation to the binomial distribution
(valid if p N or (1xp) N>5 or 10 (Armitage and
Berry, 1994)). For N, we took a value of 100, which
reflected the median population size in the obser-
vations. For each simulated situation, we assessed
the range of possible outcomes for the mbr and
mf prevalence relationship, by randomly sampling
from the probability distributions that describe the
variability. We then determined the 2.5th to 97.5th
percentile range for the possible outcomes.
Secondly, the predicted quantitative relation
between mf prevalence and geometric mean mf in-
tensity (GMI) levels in mf-positives should match
with observations. To prevent bias by variation in
the age-composition of the sampled populations, we
plotted observed and simulated values by age group.
Simulation results are summarized in a curve that
shows average GMI by mf prevalence. Observed
data were obtained by searching PubMed for pub-
lished studies presenting age-specific data on mf
prevalence and geometric meanmf intensity for Sub-
Saharan African communities. The search strategy
with inclusion and exclusion criteria is documented
elsewhere (Stolk et al. 2004). We only considered
studies that used mf counts in 20 mL night blood
smears for the mf counts, because this is the default
diagnostic test embedded in LYMFASIM.
Thirdly, simulated age-patterns of mf prevalence
should mimic the observed patterns for different
endemicity levels. For testing this, we used the same
data as in the assessment of the relation between mf
prevalence and GMI, and additional studies that
only presented prevalence data. Observed data were
grouped according to the overall mf prevalence level
in the community (very low, low, intermediate or
high mf prevalence). These observations were then
compared with model-predicted age-patterns in mf
prevalence for different mbr values. Biting rates were
not known in the field studies; we selected values
for the mbr that matched with the average overall
prevalence in each of the four groups. Unsuccessful
runs, which by chance died out during the burn-in
phase of the simulation while a stable endemic
situation was expected, were not included in the
current analysis. This only occurred with low mbr
values.
Simulations based on nominal parameter values
and sensitivity analysis
To investigate the behaviour of the model, we
simulated the impact of a 6-year mass treatment
programme on trends in mf prevalence. In our
default simulations, we performed four series of 500
repeated runs, using the parameter values that were
derived in the current study. The four series only
differed with respect to the assumed biting rate
(mbr=500, 750, 1000 or 2000). Assumptions about
treatment are given in Table 3. In view of the large
uncertainty about the effects of drug treatment on
adult worms, we do not claim to simulate a specific
treatment regimen. Yet, the chosen parameters are
in the range of ‘guesstimates ’ for existing antifilarial
drugs and drug combinations (see Stolk et al. (2005)
for a discussion of available evidence). Each simu-
lation run starts with a burn-in period and the
resulting endemic equilibrium situation is taken as
pre-treatment, time 0, situation. At time 0, the first
treatment is provided and subsequent treatments are
given with one-year intervals. The population is
followed for 20 years after the start of treatment, via
yearly epidemiological surveys. In years 0, 1, 2, 3, 4,
and 5, the epidemiological surveys just precede the
treatment. The results per series of runs were sum-
marized by calculating the average mf prevalence at
each survey, together with the 5th to 95th percentile
range.
In a univariate sensitivity analysis, we assessed
how the projected trends changed under other model
parameter assumptions. With the mbr fixed at 750
bites per person per month, we performed new series
of 500 repeated runs each. In each series, one of
the model assumptions was assigned a different value
from that in the default parameterisation; all other
parameters kept their nominal value. Alternative
values were usually chosen by multiplying the
nominal value by 2/3 or 3/2 (or, if the nominal
value of a proportion p was >50%, by multiplying
(100xp) by these factors). For nominal proportions
of 0% or 100% we chose alternative values that were
still considered realistic : we used 0.40 as alternative
value for relative exposure at birthE0 (0 in the default
model) and 85% as alternative value for the fraction
mf killed per treatment (100% in the default model).
Other parameters were treated in a more qualitative
manner. The demographic parameters were changed
as a group, to simulate a younger population with
somewhat higher fertility rates and higher mortality
rates in adults (representing the lowest income
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Downloaded: 20 Nov 2008journals.cambridge.org
countries in sub-Saharan Africa). The uptake curve
was replaced by other curves with weaker or stronger
density dependence, corresponding to the confidence
interval around the density-dependence parameter of
the nominal equation (see Appendix 2). As alterna-
tive for the semi-systematic compliance pattern de-
scribed above, we considered completely random or
completely systematic compliance patterns. Lastly,
as alternative for random variability in the fraction of
worms killed by treatment, we considered a situation
where treatment effects vary between but not within
individuals. i.e. any variation in treatment effects is
related to individual characteristics and some indi-
viduals always have a good response to treatment,
while others always respond poorly.
RESULTS
Quantification of the model for Africa
The life table and fertility rates are shown in Fig. 2A
and B (solid lines). With these parameters, the
pyramidal-shaped structure of the African popu-
lation is reasonably well approximated (Fig. 2C, grey
bars).
Table 1 gives the values of other LYMFASIM
parameters. The estimated value for parameter
aE was 0.26, indicating that the probability distri-
bution of exposure levels to mosquito bites is very
skewed. The estimated value for the parameter srwas
0.00088.
With the estimated parameter values, LYMFA-
SIM predictions fitted well to the epidemiological
data from the African region (Fig. 3). Data about the
relationship between the average mbr and overall mf
prevalence were available from 11 locations in 4
countries (Table 2). As Fig. 3A illustrates, themodels
could simulate the entire range of observed mf
prevalence levels, with values up to 40%, by varying
the monthly biting rate parameter within a realistic
range. The grey-shaded area in Fig. 3A indicates that
most observations are within the range of possible
model outcomes if model projections were subjected
to the same sources of variation as the field data
(see Materials and Methods section above for ex-
planation). Fig. 3B shows that the model-predicted
relation between mf prevalence and geometric mean
mf intensity in the positives reflects the general pat-
tern in thedata from9locations in4studies (Brengues,
1975; Gyapong et al. 1993, 1998; Boakye et al. 2004).
The biting rate does not influence this relationship.
Fig. 3C shows that the predicted age-prevalence
pattern captures themain trend in locationswith very
low, low, intermediate or high overall mf prevalence.
Data came from the 4 studies cited above, plus 7 other
studies (McGregor, Hawking and Smith, 1952;
McFadzean, 1954; Brengues, Subra and Bouchite,
1969; Juminer,Diallo andDiagne, 1971; Ripert et al.
1982; Akogun, 1991; Anosike et al. 2005). The mf
prevalence increases with host age until a stable level
is reached in adults. The biting rate only influences
the average mf prevalence level and not the shape of
the age-prevalence pattern.
Default simulations and sensitivity analysis
Fig. 4 shows the results of our simulations using
the nominal parameter values for areas with varying
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Fig. 2. Quantification of demographic parameters in
LYMFASIM for modelling an African population.
A: Survival curve, showing the survival probability as a
function of age. B: Age-specific fertility rates, expressed
as the mean number of births per female per year.
C: Age-structure of the population that is simulated with
the specified survival curve and fertility rates. The solid
lines in A and B and the grey bars in C correspond to the
default assumptions. The dotted lines and white bars give
the alternative assumption which was used in the
sensitivity analysis of simulating a younger population
(with higher fertility and higher adult mortality rates).
Black diamonds show published estimates of the
population pyramid for the sub Saharan Africa
population in 2002 (US Census Bureau, 2004).
Modelling LF transmission and control in Africa 1587
Downloaded: 20 Nov 2008journals.cambridge.org
average mbr, with the treatment assumptions of
Table 3. Mass treatment led to elimination in areas
with low average biting rates (mbr=500), but to rapid
recrudescence in areas with high biting rates
(mbr=1000 or 2000). In areas with a biting rate of
750, the intervention reduced mf prevalence to low
levels, but there was a tendency for slow recrud-
escence. (The grey area in Fig. 4 does not have the
same interpretation as that of Fig. 3A. The range
of possible outcomes in Fig. 4 is much narrower,
because model outcomes are conditional on the
assumed constant mbr value and because they ignore
the non-simulated variability in mf prevalence
measurement resulting from random sampling of the
human population.)
Fig. 5 shows the results of the sensitivity analysis
for a location with mbr=750. Four of the seven
parasite biology parameters had a strong influence on
the predicted mf prevalence levels before and after
treatment, namely, the average worm lifespan, the
rate of mf production per female worm, the average
mf lifespan, and the success ratio of L3 larvae be-
coming established worms. While the strength and
direction of density dependence in the uptake of
infection by the mosquito barely influenced the
pre-treatment mf prevalence, they had a very strong
impact on the long-term impact of mass treatment
and elimination prospects. Of the exposure-related
parameters, the variability in exposure was most
influential. Increased variability reduced the pre-
treatment mf prevalence, but also led to faster re-
crudescence of infection after cessation of treatment.
Higher values for the exposure of newborns and
lower values of the age at which exposure achieves its
maximum both resulted in a somewhat higher pre-
treatment mf prevalence, but had little impact on the
observed value after treatment. The variability in mf
counts determined the probability of false-negative
outcomes in mf counts, but not the underlying true
level of infection. Its influence was largest in the pre-
treatment situation. The mf prevalence was some-
what lower in a younger population. The impact
of mass treatment was strongly reduced when we
assumed lower coverage, systematic compliance, or a
lower treatment effect on adult worms. The amount
of variability in the latter effect was not very im-
portant, as long as the variation occurred at random.
However, if drug efficacy varied systematically be-
tween persons (so that some people always respond
poorly, while others might have a good response), the
overall impact of mass treatment was substantially
reduced.
DISCUSSION
With the advancement of the Global Programme to
Eliminate Lymphatic Filariasis, there is a growing
demand formodels that predict the long-term impact
Table 1. LYMFASIM parameters with their nominal values for simulating transmission of lymphatic
filariasis by Anopheles mosquitoes in African communities
Parameter symbol and description
Nominal
value Source
mbr Monthly biting rate, i.e. average number of mosquito bites per
adult person per month (range of possible values)
100–4000 This paper
E0 Relative exposure at birth (fraction of average exposure in adults) 0 Expert opinion
amax Age at which exposure to mosquitoes reaches its maximum level 20.0 (Subramanian et al. 2004)
aE Shape-parameter for the gamma-distribution describing variability
in exposure to mosquito bites between individuals
0.26 This paper
a Parameters of the mathematical function describing the uptake
of infection by Anopheles mosquitoes (the ‘uptake curve’)*
1.666 This paper
b 0.027 (Appendix 2)
c 1.514
v Fraction of the L3 larvae, resulting from a single blood meal,
that is released by a mosquito
0.1 Expert opinion
sr Success ratio, i.e. the probability that an infectious L3 larva, which
is released during a mosquito blood meal, survives to develop
into a mature adult worm (fraction)
0.00088 This paper
Ti Duration of the immature stage of the parasite in the human
host (months)
8.0 (World Health
Organization, 1992)
Tl Average lifespan of adult parasites (years) 10.0 (Subramanian et al. 2004)
aTl Shape parameter of the Weibull distribution that describes the
between-worm variability in the worm lifespan (mean=1)
2.0 Expert opinion
r0 No. of mf produced per female parasite (per month per 20 mL of
peripheral blood) in the presence of at least 1 male worm
0.58 (Subramanian et al. 2004)
Tmf Mean lifespan of microfilaria (months) 10.0 (Plaisier et al. 1999)
k Aggregation parameter of the negative binomial distribution
describing the variability in mf counts in 20 mL blood smears
for an individual
0.33 (Subramanian et al. 2004)
* L3=a(1xexp (x(bM)c). See Appendix 2 for further explanation.
Wilma A. Stolk and others 1588
Downloaded: 20 Nov 2008journals.cambridge.org
of control measures.We quantified the LYMFASIM
simulation model (Plaisier et al. 1998) for use in
African villages where Anopheles species act as main
vectors, using a wide variety of reported data.
Particular effort was made to test whether the model
adequately captured general epidemiological patterns
and differences between communities. By varying
the average monthly biting rate within a realistic
range (of about 100 to 4000 bites per person per
month), we could simulate the entire range of ob-
servedmf prevalence levels, which ranged up to 40%.
The relationship between mf prevalence and geo-
metric mean mf intensity in the mf-positives, as well
as the general age-patterns of mf prevalence matched
with observations.
Model behaviour
We performed large numbers of simulations to
examine whether the model behaved as expected and
to provide insight into the influence of the many
model parameters on the predictions. The model-
predicted trends in mf prevalence during and after
a 6-year mass treatment programme show that
the elimination prospects are best in areas with
low biting rates and low pre-treatment endemicity
levels. The probability and rate of recrudescence
after stopping treatment increase with higher biting
rate and pre-treatment endemicity levels. These
predictions are plausible, but remain to be validated
against observed data (see below).
The sensitivity analysis provides much infor-
mation about the effects of parameter values. Ad-
justing the success ratio, average worm burden, rate
of mf production per female worm, and average mf
lifespan resulted in major changes in the predicted
pre-treatment mf prevalence, implying that the
predictions are no longer in agreement with the data
of Fig. 3A and that post-treatment predictions are
not valid. This does not necessarily mean that the
alternative parameters values are unrealistic : a better
fit might be obtained by adjusting the fitted or other
model parameters.
Our sensitivity analysis confirmed the importance
of density dependence assumptions as reported by
others (Duerr et al. 2005). We have paid particular
attention to the quantification of the uptake curve, but
some uncertainty remained about the strength of
density dependence. Changing these assumptions
had no impact on the predicted pre-treatment mf
prevalence level or the goodness of fit in Fig. 3 (not
shown). Yet, it strongly influenced the predicted
post-treatment prevalence 20 years later. Thus, the
remaining uncertainty about the strength of density
dependence hinders accurate predictions of long-
term effects ofmass treatment.We also confirmed the
importance of variability in exposure to mosquito
bites for elimination prospects (Duerr et al. 2005).
A higher degree of variability causes stronger
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Fig. 3. Comparison of model outcomes (based on
nominal parameter values, Table 1) with data collated
from literature. A: Relationship between monthly biting
rate (mbr) and overall mf prevalence in the population.
The solid line corresponds to model predictions, while
the markers represent data presented in Table 2.
The grey-shaded area shows the range of possible model
outcomes if time-dependent or measurement error
variation in the mbr and sampling variation in mf
prevalence is taken into account (see Materials and
Methods for further explanation). B: Relationship
between observed mf prevalence and geometric mean mf
intensity (GMI) in 20 mL of blood, based on age-specific
data. The overlapping lines show the model-predicted
relation for monthly biting rates of 500, 750, 1000 and
2000. The markers show the observations; observations
that were made in different age groups from the same
community share the same symbol. C: Relationship
between mf prevalence and host age. The thin grey lines
show the observed age-patterns in different communities.
Different line types were used for villages with very low
(dashed), low (dotted), intermediate (solid) or high
(dot-dashed) overall mf prevalence. The thick black
lines of the same type show the corresponding model
predictions which were obtained with mbr of 400, 500,
750 and 2000 respectively.
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aggregation in the distribution of the parasites over
humans (some people harbouring many worms
and others few or none); this increases the mating
probabilityofworms, especiallywhenwormnumbers
are low, and leads to higher risk and rates of recrud-
escence after stopping treatment. Differences be-
tween communities in the amount of variability result
in variable elimination prospects (Dadzie et al. 2004).
As previously shown, post-control predictions
depend heavily on assumed coverage and compliance
patterns (Plaisier et al. 2000; Stolk et al. 2003;
Table 2. List of published studies that provide information about both the monthly biting rate and mf
prevalence levels in African communities where Anopheles acts as main vector for lymphatic filariasis
Reference
Mosquito
species Country Location
Average
MBR* Mf diagnosed
Mf
prevalence
(Kuhlow and Zielke, 1978) A.f., A.g. Liberia Bolilo 1514 n.r. 18.3%
(Kuhlow and Zielke, 1978) A.f., A.g. Liberia Gbandu 3038 n.r. 20.0%
(Kuhlow and Zielke, 1978) A.f., A.g. Liberia Kaikatown 510 n.r. 10.3%
(Kuhlow and Zielke, 1978) A.f., A.g. Liberia Grahntown 92 n.r. 12.5%
(Wijers and Kiilu, 1977);
(Wijers and Kinyanjui,
1977)
A.f., A.g. Kenya Jaribuni 898 Counting chamber
(100 mL)
22.0%
(McMahon et al. 1981) A.f., A.g., C.q. Tanzania Tawalani 1071 DEC-provocative test
and counting chamber
(100 mL)
28.3%
(McMahon et al. 1981) A.f., A.g., C.q. Tanzania Machui 491 DEC-provocative test
and counting chamber
(100 mL)
18.5%
(Bushrod, 1979) A.f., A.g. Tanzania Kwale 409 n.r. 17.0%
(Maasch, 1973; Brengues
et al. 1968)
A.f., A.g. Burkina
Faso
Tingrela 711 n.r. 36.0%
(Maasch, 1973) A.f., A.g., A.m. Liberia Bassa Point 825 Blood smear (3r20 mL
finger prick night blood)
34.6%
(Maasch, 1973) A.f., A.g., A.m. Liberia Cowfarm 2393 Blood smear (3r20 mL
finger prick night blood)
36.0%
Abbreviations: A.f.=Anopheles funestus ; A.g.=Anopheles gambiae ; C.q.=Culex quinquefasciatus ; A.m.=Anopheles melas ;
MBR=monthly biting rate; n.r.=not reported.
* The averageMBR is themean biting rate over a period of 1 year, calculated as 1/12 * annual biting rate. The annual biting
rate was estimated from landing catches, which were performed with regular intervals in a period of 12 months.
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Fig. 4. Model-predicted trends in mf prevalence during
and after a 6-year mass treatment programme. Treatment
takes place in the first 6 years of the simulation with the
assumptions of Table 3. The dotted lines and arrowheads
on the top-axis indicate the times of treatment. The thick
lines show the average predicted trends for monthly
biting rates of 500 (solid), 750 (dashed), 1000 (dotted)
and 2000 (dot-dashed). The grey areas around each line
indicate 5th to 95th percentile range of simulation results
at each time. The results are based on 500 simulation
runs. The trends are based on yearly measurements at
t=0, 1, 2, …, 20; fluctuations between these time-points
are not shown.
Table 3. Parameter assumptions about mass
treatment and drug efficacy
Parameter Nominal value
Number of treatment rounds 6
Coverage 80%
Individual compliance to
treatment in subsequent rounds*
‘semi-systematic ’
Fixed proportion of mf
killed by each treatment
100%
Mean proportion of
worms killed by each treatment
50%
Standard deviation of the beta
distribution describing the amount
of random variability in the fraction
of worms killed by treatment#
0.2
* See Appendix 1 for explanation.
# The default assumption is that this variation occurs
randomly between treatments. The sensitivity analysis
considered the alternative assumption that variation occurs
systematically between individuals and that there is no
variation within individuals.
Wilma A. Stolk and others 1590
Downloaded: 20 Nov 2008journals.cambridge.org
Michael et al. 2004). This underlines the importance
of assessing their actual values for evaluation of
treatment programmes. The effects of treatment on
adult worms are also very important, and uncertainty
about this affects our ability to predict accurately
post-treatment trends in infection.
Model validation
A strength of our validation approach is the com-
parison of the model predictions to data from a range
of different communities. This helped to identify
both the general pattern and realistic deviations.
Deviations from the model-predicted average re-
lationships can be large. See for example Fig. 3A.
The model predicts a clear transmission threshold in
the biting rate: if the average monthly biting rate
drops below the value of 400, the basic reproduction
ratio (R0) becomes too low and the infection will
die out (R0<1). Such a threshold is theoretically
plausible and our estimate was of the same order
of magnitude as an earlier published estimate
(Michael et al. 2006). However, the threshold pattern
is not clearly visible in the data. Several reasons
may be given as explanations for this. Firstly, the
data are subject to measurement, sampling, or time-
dependent variation. The latter is particularly rel-
evant because trends and fluctuations in biting rates
are not immediately reflected in mf prevalence levels.
Because of these factors, the observations do not lie
on the predicted curve, but can lie anywhere in the
grey-shaded area of Fig. 3A. Secondly, local condi-
tions can differ from the average conditions assumed
in our model (e.g. with respect to variability in ex-
posure, the age-structure of the population or
anthropophagy of the local vector), leading to a dif-
ferent transmission threshold (Basa´n˜ez et al. 2002;
Duerr et al. 2005).
The model predictions were only compared with
cross-sectional data from treatment-naı¨ve com-
munities. A next step is to compare model predictions
with longitudinal, post-treatment data. Evaluation
data from the ongoing mass treatment programmes
will be very helpful. Data collected during the first
treatment years may not yet be very powerful for
validation, because the model parameters are not
uniquely identifiable. For example, effective mass
treatment leads to a strong reduction in transmission.
Uncertainty about treatment parameters (coverage,
compliance, drug efficacy) precludes the accurate
quantification of the remaining transmission. The
most informative data for validating the underlying
biological assumptions are probably those that are
collected after cessation of prematurely interrupted
or unsuccessful elimination campaigns: from the
rate of recrudescence after cessation we can learn
much more than from the rate of decline during
mass treatment. Such data are available only for a
few African villages (Meyrowitsch, Simonsen and
Magesa, 2004a, b). It would be interesting to test the
Mf prevalence at t=0
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Fig. 5. Sensitivity analysis: impact of changes in parameter values and other model assumptions on the predicted mf
prevalence before and after an intervention with 6 yearly rounds of mass treatment. Post-treatment mf prevalence was
measured in year 20, i.e. 15 years after the 6th (last) treatment round. The vertical black lines in each graph show the
mf prevalence levels that were predicted by the model with nominal parameter values (Table 1). Markers show the
results obtained under alternative assumptions. On the left side of the graph we provide descriptive labels for the
parameters or assumptions concerned. On the right side of the graph we specify the alternative value for the parameters
concerned, with the 1st value corresponding to the black bullet and the 2nd value (if available) to the white bullet. See
Materials and Methods for considerations in choosing alternative values.
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model against these data, but more data are needed to
understand the general trends and possible devi-
ations depending on local factors. Since the GPELF
strives to achieve success in elimination programmes,
such data will probably remain scarce for some time.
Uncertainty
One of the uncertain aspects in models for LF
transmission is the role of acquired immunity.
While strong acquired immunity was included in the
Pondicherry model (Subramanian et al. 2004), we
found that evidence from the African continent is not
consistent with this type of immunity as a strong
regulatory factor of parasite population abundance
(Stolk et al. 2004). The difference between the
Pondicherry and Africa model is somewhat unsatis-
factory: it is rather unlikely that this mechanism
plays a role in one region, but not in another. The
new challenge is to define whether a model without
acquired immunity can explain the observed patterns
from Pondicherry if we take account of specific local
conditions. In our earlier paper we discussed possible
explanations (Stolk et al. 2004).
The discussion about acquired immunity points at
a more general problem in modelling LF trans-
mission, i.e. our incomplete understanding of the
transmission dynamics, the nature and magnitude of
regulatory processes, and the effects of treatment.
For example, we rejected the hypothesis that strong
acquired immunity leads to a lower mf prevalence
in elderly individuals, but we cannot exclude the
operation of other regulatory immune processes
(Woolhouse, 1992). Similarly, we lack knowledge
about other factors that could influence the predic-
tions, such as the occurrence of density dependence
in the various processes of the parasite’s life cycle
(Duerr et al. 2005; Churcher, Filipe and Basa´n˜ez,
2006), or the possibility that parasites become re-
sistant against the antifilarial drugs (McCarthy,
2005; Schwab et al. 2005, 2007). We can also ques-
tion the assumption that biological parameters such
as the lifespan of adult worms and mf do not vary
between locations. In the absence of evidence about
these factors or data to validate assumptions, we kept
the model parsimonious, trusting that the model
captures the critical processes. Yet, this underlines
the need to validate the model against longitudinal,
post-treatment data, when they become available.
Application of the model
Themodel can be a useful tool for decision support in
LF elimination programmes in the African region.
For example, the model can help to determine the
coverage and number of treatment rounds required
for LF elimination under the different circumstances
that occur in the African region using earlier pub-
lished methods (Winnen et al. 2002; Stolk et al.
2003). Further, detailed analysis of predicted trends
after cessation of mass treatment can elucidate how
the probability of achieving elimination depends
on outcomes of epidemiological surveys in the end
phase of treatment programmes and early years of
follow-up. This will help to determine criteria for the
cessation of mass treatment and to design surveil-
lance schemes to monitor for possible recrudescence.
Clearly, all predictions need to be accompanied by
critical assessment of uncertainty. Making this un-
certainty explicit can contribute to better and pru-
dent decision-making.
Conclusion
In conclusion, we have developed a genericmodel for
LF transmission by Anopheles mosquitoes in Africa,
which captures the most important factors of LF
dynamics and can easily be adjusted to specific cir-
cumstances by changing assumptions about expo-
sure to mosquito bites. Its predictions are consistent
with cross-sectional parasitological and entomologi-
cal data. Although further validation against longi-
tudinal, post-treatment data is required, the model
already provides an important tool for decision-
making in LF elimination programmes. The model
can help to assess when ongoing elimination activities
in African populations can be stopped and to
design surveillance schemes. In view of the rapid
expansion of the Global Programme to Eliminate
Lymphatic Filariasis, these issues need to be ad-
dressed urgently.
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APPENDIX 1. THE LYMFASIM SIMULATION
MODEL
Simulation technique
LYMFASIM is based on the technique of stochastic
microsimulation (Habbema et al. 1996). This tech-
nique is characterized by the simulation of individual
life histories of fictitious persons, who in aggregate
constitute the population of interest. The computer
program tracks expected changes over time in the
population composition and the relevant character-
istics of each individual.
Model structure
Themodel simulates the demographic processes that
drive population changes. Births and deaths are
modelled as stochastic events in the life course of
individuals. The expected number of newborns per
time step depends on the number of females per age
group and age-specific fertility rates. Random num-
bers define the realized number of newborns entering
the population per time step. The age of death varies
between individuals; it is defined as soon as a person
enters the population by drawing a random variate
from a life table. Immigration and emigration are not
considered in the LYMFASIM model.
Each simulated individual has a number of
characteristics, which define personal risk factors
and behaviours that are relevant for transmission
and control. Some of these characteristics are fixed,
such as gender, attractiveness to mosquitoes, or
willingness to comply with treatment. They are
determined by randomly drawing a value from pre-
specified probability distributions. Other character-
istics can change during the course of a simulation,
such as the age-dependent fertility rates and
exposure to mosquitoes. Because of their personal
characteristics, individuals may be predisposed to
heavy or light infections. The infection status is the
most important characteristic of human individuals.
LYMFASIM simulates the transmission of parasites
from person to person and tracks changes in the
number of worms per individual.
A schematic representation of the variables and
processes involved in transmission is provided in
Fig. 1. Because LYMFASIM uses one-month time
steps, all rates are expressed permonth. Themonthly
transmission potential (mtpi) reflects the number of
L3 larvae that are released to a person per month. On
average, only a small proportion (called the success
ratio, sr) of the released larvae will survive to develop
further into adult worms; a chance process defines
how many L3 larvae survive per month. The life
course of surviving worms is simulated at individual
worm level. Worms are immature during a period Ti
and their average lifespan is Tl. The lifespan varies
between worms according to a Weibull distribution
with shape parameter aTl. We assume that all adult
females are inseminated and produce microfilariae
(mf), if at least one male worm is present in the
human body. Parameter r0 gives the mf production
per female worm, expressed as the number of mf per
month and per 20 mL of peripheral blood. Mf have a
mean lifespan Tmf and their monthly survival is
given by 1x1/Tmf. Mf are not simulated at the
individual level ; the model merely calculates the
average mf density in the blood per individual (ex-
pressed in mf per 20 mL night finger prick blood).
LYMFASIM has the option to include acquired
immunity, which either reduces the probability of
L3 larvae to develop into adult worm or reduces
the mf output by female adult worms. Both me-
chanisms result in a lower mf count in elderly com-
pared to young adults. As explained in the main text,
acquired immunity is not included in the current
model.
The ‘uptake curve’ (in this case given by a math-
ematical function with parameters a, b, and c) de-
scribes the deterministic relation between the mf
density in the human blood of person i and the
average number of L3 larvae that develop in a mos-
quito after feeding on that person (L3i). The average
number of L3 larvae taken up by mosquitoes is given
by the weighted average of the uptake from all in-
dividuals, the weights reflecting the relative exposure
of each individual to mosquito bites (Ei, see below).
This average number is multiplied by a factor v to
calculate the average number of L3 larvae that is
released per bite, L3. The factor v accounts for the
proportion of L3 that is lost due to mosquito death
and the proportion of L3 that does not leave the
mosquito when it bites.
The relative exposure of an individual (Ei) in-
dicates how many mosquito bites a person gets per
month. It is expressed as a fraction of the average
number ofmosquito bites received per adult male per
month (monthly biting rate, mbr). LYMFASIM
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accounts for age (and optional sex) variation in ex-
posure and random variation in individuals’ attract-
iveness for mosquitoes. Here we adopt the common
assumption that exposure increases with body
surface during growth in childhood and stabilizes in
adults (Duerr et al. 2005; Smith et al. 2006). We
approximate this by a linear increase in relative
exposure from E0 at birth to the adult (maximum)
level that is achieved at age amax. The random, not
age-related variability in exposure is described by
a gamma distribution with shape parameter aE
and mean 1. An individual’s relative exposure
does not only determine his/her contribution to
the mean L3-load of mosquitoes, but also the num-
ber of L3-larvae received: the monthly transmission
potential (mtpi) is calculated as the mean number of
L3 larvae released per mosquito bite (L3, see above)
multiplied by the mbr and the individual’s relative
exposure (Ei). We assume that the mbr is constant
over time, ignoring seasonal variation and other time
trends.
Control strategies
To simulate the impact of mass drug administration,
the user must specify the exact moments of treatment
(year, month), the drug or administration regimen
applied with its efficacy, the fraction of people treated
per round (coverage), and the compliance pattern.
The three main effects of treatment are: (1) a
fraction of adult worms is killed; (2) a fraction of
female adult worms is permanently sterilized (i.e.
they stop producing mf); and (3) a fraction of mf
is killed. The fraction of parasites affected can be
constant or can vary according to a chosen prob-
ability distribution function. In addition, for each
of the three mechanisms, the user may specify a
fraction of treated patients with no or full effect of
treatment (i.e. the fraction of parasites affected is
respectively 0 or 1). All stochastic variables related
to the effects of treatment are by default assumed
to be independent and to be generated for each
person at each treatment. As an alternative, the
treatment efficacy can be attributed as a fixed
characteristic to an individual, who in that case al-
ways responds in the same way to treatment.
Temporal reductions in the mf production can also
be simulated (Plaisier et al. 1998), but these are not
included here.
The compliance pattern describes the tendency
of persons to participate in repeated treatment
rounds. In case of random compliance, all individuals
have the same probability to be treated (equal to
the fraction covered). In case of systematic com-
pliance, each person in the population is character-
ized by an invariable compliance factor (a random
number between 0 and 1), which results in a treat-
ment probability of either 1 (for compliance
factorfcoverage) or 0 (for compliance factor>
coverage). Consequently, if coverage is constant
over time, some individuals will always be treated
while the remaining persons are never treated. In the
case of semi-systematic compliance pattern, the com-
pliance factor indicates a person’s tendency to par-
ticipate. Random numbers define whether an
individual is actually treated or not. The latter
pattern is presumably most realistic (Plaisier et al.
2000).
LYMFASIM also allows the simulation of
selective treatment. In that case, treatment is only
provided to those persons who were Mf positive in
the most recent survey (which may take place in
the same month as treatment, see below). Coverage
and compliance play no role. Vector control can be
modelled as a percentage reduction of the monthly
biting rate during a specified period. The number of
such periods, their duration and the reduction in
monthly biting rate can be chosen.
Model output
At chosen times surveys can be simulated to deter-
mine the mf counts for all individuals in the popu-
lation. We assume that this is done by microscopic
examination of a 20 mL night blood smear. The
counts are variable and are assumed to follow a
negative binomial distribution with clumping factor
k and the simulated mf density as mean expected
outcome. The results can be summarized by different
population-level indicators of infection: the mf
prevalence, the geometric or arithmetic mean num-
ber of mf per smear, or the frequency distribution
of mf counts in the population. Survey results can be
tabulated by age group and gender.
Running the model
The program starts by creating an initial population,
with specified size and age distribution. At the start
of the simulation, some people are infected via some
external force of infection. The model simulates how
the population develops and how the infection level
and other individual characteristics change in each
one-month time step. To reach an endemic equilib-
rium situation and a stable age structure of the
population, a simulation must generally cover a
period of many decades. This is called a ‘burn-in’
period. Since the characteristics of persons are de-
termined by chance or change as a result of stochastic
processes, the result of one simulation run represents
only one of many possible outcomes. Repeated runs
will give slightly different results. The variability
between runs reflects natural variation in real world
populations, conditional on the appropriateness of
the model structure. Simulations always have to be
repeated to estimate the mean outcome and gain an
insight into variability.
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APPENDIX 2. QUANTIFYING THE UPTAKE CURVE
FOR ANOPHELES
Methods
The uptake curve describes the relationship between
mf density in the human blood and the number of
L3 larvae developing in mosquitoes after feeding. To
quantify this curve for Anopheles, we analyzed data
about the average number of L3 larvae developing in
a batch of mosquitoes that fed on an infected human
with known mf density. Raw data were available
from a field study in Ghana (Boakye et al. 2004).
The few available data from published feeding
experiments were also used (Bryan and Southgate,
1988a, b ; Southgate and Bryan, 1992). Summary
information of the different studies is provided in
Table 4.
To enable combined analysis of the data from dif-
ferent studies, we first standardized the mf counts to
the expected count in a 20 mL finger prick blood
smear. When reported mf counts were based on
f100 mL finger prick blood, we only applied a cor-
rection for volume. To transform mf count in 1 mL
venous blood to corresponding count in 20 ml finger
prick blood, we used the relationship thatwas derived
bySnowandMichael (2002) :y=0.037x+0.1449x2x
0.0309, where: y=log10 (Mf count in 20 mL
blood+1), x=log10 (Mf count in 1 ml blood+1).
Subsequently, we quantified the relationship
between the standardized mf count in the human
blood (mf per 20 mL) and the mean number of L3
developing in mosquitoes after feeding, by fitting
equation 1 to the data.
L3=a(1x exp (x(bM)c) (1)
with L3=the average number of L3 larvae de-
veloping in mosquitoes; M=the mf density in
human blood as counted in a 20 mL night blood
smear; a=the maximum number of L3 larvae that
can develop in mosquitoes ; b=1/scale ; c=power-
parameter. Depending on the value of the parameter
c, this curve takes a saturating (c<1) or sigmoid form
(c>1). The latter is suitable for describing ‘facili-
tation’ in the mf uptake and development, which is
assumed forAnopheles : the number of L3 developing
in mosquitoes initially increases more than pro-
portional with the mf density in the human blood,
but at higher densities limiting mechanisms get the
upper hand so that saturation occurs (Southgate and
Bryan, 1992; Duerr et al. 2005).
Using the non-linear regression procedure (PROC
NLIN) in SAS (v8.2), we estimated the values of
parameters a, b and c with the least squares method.
Observations were weighed for the number of
mosquitoes examined. The weights (Wi) were cal-
culated as:
Wi=
ffiffiffiffi
xi
p
,Xn
i
ffiffiffiffi
xi
p
(2)
with xi the number of mosquitoes examined for
observation i, and n the total number of observations
included in the analysis. To prevent exclusion of
observations with zero mf counts, we replaced the
zeros by half the detection limit (with the detection
limit being calculated as 1/(total blood volume ex-
amined in mL)*20 mL).
Likelihood-based confidence intervals were cal-
culated for parameter c (Kalbfleish, 1979). Confi-
dence boundaries for this parameter were derived
Table 4. Summary information about the data used for quantifying the vector uptake curve for
Anopheles mosquitoes
Methods used for
measuring mf intensity
Reported mf
intensity in
mf/mL (range)
No. of
batches of
mosquitoes
examined
Mosquito
species
Mean no. of
mosquitoes
dissected per
batch (range)
Mean no. of
L3 recovered
from mosquitoes
in a batch (range)
(Boakye et al. 2004)
Mean mf count in 9r100 mL samples of
finger prick blood, counting chamber
2630 (0 – 9740) 20 A.f., A.g. 15.9 (1–34) 1.23 (0–3.31)
(Southgate and Bryan, 1992)
Mf count in a 1r100 mL sample of
finger prick blood, counting chamber
1490 (1300–1735) 3 A.g. 39.7 (NA) 0.52 (0.28–0.87)
1434 (1190–1677) 3 A.a. 25.3 (NA) 1.48 (1.11–1.67)
1408 (920–1657) 3 A.mr. 87.7 (NA) 1.16 (0.79–1.56)
1367 (930–1735) 3 A.f. 38.7 (NA) 0.67 (0.24–1.13)
(Bryan and Southgate, 1988a, b)
Mf count in 1r1 mL venous blood
sample, membrane filtration;
sometimes: mf count in 20 mL
finger prick blood
312 (0–11400) 20 A.g. 182.9 (80–276) 0.16 (0–0.7)
286 (0–11400) 18 A.a. 159.7 (35–294) 0.15 (0–0.81)
435 (0–11400) 11 A.ml. 31.5 (1–110) 0.32 (0–1.37)
Abbreviations: A.f.=Anopheles funestus ; A.g.=Anopheles gambiae ; A.a.=Anopheles arabiensis ; A.mr.=Anopheles merus ;
A.ml.=Anopheles melas ; mf=microfilariae.
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iteratively, by searching for the highest and lowest
possible value that did not give a significantly worse
fit to the data as assessed via the sum of squared
errors (SSE). The maximum acceptable SSE (cor-
responding to the boundaries of the 95% confidence
interval for parameter c) is given by SSEopt+3.84*
scale, with the scale calculated as the sum of squared
errors of the optimized model divided by the corre-
sponding degrees of freedom (SSEopt/d.f.).
Results
The observations and estimated curves are shown
in Fig. 6. There were 81 observations in total. The
number of mosquitoes on which observations
were based varied widely, from 1 to 294. Point esti-
mates of the parameters of equation 1 were: a=1.67,
b=0.027, and c=1.51. The solid line in Fig. 6
shows the shape of the uptake curve. The value of
c>1 gives the curve a sigmoid shape, indicating that
there is facilitation in the relationship between mf
density in the human blood and the L3 yield per mf.
However, the data used for estimation were highly
variable and some uncertainty remains about the
strength of density dependence. The dotted and da-
shed lines correspond to the upper and lower
boundaries of the 95% confidence interval for the
parameter c, respectively resulting in curves with
weaker facilitation (a=2.11, b=0.013, c=0.81) or
stronger facilitation (a=1.40, b=0.036, c=2.72).
Note that the dotted curve in fact shows limitation:
the L3 yield per mf is highest at the lowest mf
density and continuously declines with increasing mf
density.
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Fig. 6. Uptake curve, showing the relation between the mf count in human blood (mf per 20 mL of blood) and the
average number of L3 developing per mosquito after a blood meal. Observations are shown as open circles and
the circle size correlates to the number of mosquitoes examined. The solid line shows the best fitting curve;
the dotted and dashed lines respectively give the curves that correspond to the lower and upper boundary for
parameter c (the severity of density dependence).
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